Stephens Inc Edwards Lifesciences Corp Transaction History

Stephens Inc

$6.77 Billion
Q3 2024

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 06, 2024	SELL	$84.3 - $94.31 $155,280 - $173,719	-1,842 Reduced 36.41%	3,217 $297,000
Q1 2024 May 15, 2024	SELL	$72.54 - $95.56 $1.32 Million - $1.73 Million	-18,132 Reduced 78.19%	5,059 $483,000
Q4 2023 Feb 13, 2024	SELL	$61.71 - $77.76 $27,769 - $34,992	-450 Reduced 1.9%	23,191 $1.77 Million
Q3 2023 Nov 14, 2023	SELL	$69.28 - $93.38 $29,651 - $39,966	-428 Reduced 1.78%	23,641 $1.64 Million
Q2 2023 Aug 14, 2023	SELL	$81.41 - $94.33 $1,465 - $1,697	-18 Reduced 0.07%	24,069 $2.27 Million
Q1 2023 May 15, 2023	SELL	$74.26 - $84.51 $13,515 - $15,380	-182 Reduced 0.75%	24,087 $1.99 Million
Q4 2022 Jan 25, 2023	SELL	$68.3 - $87.44 $348,125 - $445,681	-5,097 Reduced 17.36%	24,269 $1.81 Million
Q3 2022 Nov 02, 2022	BUY	$82.37 - $107.29 $382,526 - $498,254	4,644 Added 18.78%	29,366 $2.43 Million
Q2 2022 Aug 03, 2022	BUY	$86.5 - $128.27 $20,760 - $30,784	240 Added 0.98%	24,722 $2.35 Million
Q1 2022 May 04, 2022	SELL	$101.96 - $128.34 $191,073 - $240,509	-1,874 Reduced 7.11%	24,482 $2.88 Million
Q4 2021 Mar 07, 2022	SELL	$106.37 - $130.68 $57,439 - $70,567	-540 Reduced 2.01%	26,356 $3.41 Million
Q3 2021 Oct 27, 2021	BUY	$102.91 - $122.75 $41,678 - $49,713	405 Added 1.53%	26,896 $3.05 Million
Q2 2021 Aug 12, 2021	BUY	$83.84 - $104.76 $43,345 - $54,160	517 Added 1.99%	26,491 $2.74 Million
Q1 2021 May 14, 2021	BUY	$78.68 - $90.67 $1.44 Million - $1.66 Million	18,282 Added 237.68%	25,974 $2.17 Million
Q4 2020 Feb 10, 2021	SELL	$71.69 - $91.23 $1.3 Million - $1.65 Million	-18,102 Reduced 70.18%	7,692 $702,000
Q3 2020 Nov 13, 2020	BUY	$67.19 - $87.44 $5,912 - $7,694	88 Added 0.34%	25,794 $2.06 Million
Q2 2020 Aug 24, 2020	BUY	$57.54 - $76.95 $1.03 Million - $1.38 Million	17,926 Added 230.41%	25,706 $1.78 Million
Q1 2020 May 14, 2020	BUY	$52.41 - $81.0 $318,705 - $492,561	6,081 Added 357.92%	7,780 $1.47 Million
Q4 2019 Feb 14, 2020	SELL	$71.7 - $82.09 $414,641 - $474,726	-5,783 Reduced 77.29%	1,699 $396,000
Q3 2019 Oct 18, 2019	BUY	$61.55 - $75.43 $2,769 - $3,394	45 Added 0.61%	7,482 $1.65 Million
Q2 2019 Aug 01, 2019	SELL	$55.74 - $64.41 $445 - $515	-8 Reduced 0.11%	7,437 $1.37 Million
Q1 2019 May 03, 2019	SELL	$47.89 - $64.05 $7,422 - $9,927	-155 Reduced 2.04%	7,445 $1.42 Million
Q4 2018 Feb 11, 2019	SELL	$46.41 - $56.94 $94,212 - $115,588	-2,030 Reduced 21.08%	7,600 $1.16 Million
Q3 2018 Nov 14, 2018	BUY	$45.7 - $58.03 $440,091 - $558,828	9,630 New	9,630 $1.68 Million
Q3 2017 Nov 08, 2017	SELL	$36.29 - $38.83 $284,186 - $304,077	-7,831 Closed	0 $0
Q2 2017 Aug 10, 2017	BUY	N/A	7,831	7,831 $926,000

Others Institutions Holding EW

# of Institutions

1,351

Shares Held

455M

Call Options Held

9.76M

Put Options Held

3.92M

Vanguard Group Inc Valley Forge, PA

62.6M
Shares

$4.24 Billion
0.08% of portfolio
Black Rock Inc. New York, NY

51M
Shares

$3.45 Billion
0.11% of portfolio
Wellington Management Group LLP Boston, MA

31.5M
Shares

$2.14 Billion
0.37% of portfolio
State Street Corp Boston, MA

26.3M
Shares

$1.78 Billion
0.07% of portfolio
Geode Capital Management, LLC Boston, MA

13.5M
Shares

$916 Million
0.07% of portfolio

View Full List

About Edwards Lifesciences Corp

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

More about EW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stephens Inc , based on Form 13F filings with the SEC.

News

Stay updated on Stephens Inc with notifications on news.

Account